Compare WST & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | DRI |
|---|---|---|
| Founded | 1923 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 20.2B |
| IPO Year | N/A | 1995 |
| Metric | WST | DRI |
|---|---|---|
| Price | $273.32 | $186.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 26 |
| Target Price | ★ $345.75 | $223.08 |
| AVG Volume (30 Days) | 675.4K | ★ 1.7M |
| Earning Date | 02-12-2026 | 12-18-2025 |
| Dividend Yield | 0.32% | ★ 3.26% |
| EPS Growth | 0.17 | ★ 9.17 |
| EPS | 6.75 | ★ 9.54 |
| Revenue | $3,017,900,000.00 | ★ $12,576,500,000.00 |
| Revenue This Year | $7.01 | $9.83 |
| Revenue Next Year | $6.20 | $4.00 |
| P/E Ratio | $40.75 | ★ $19.28 |
| Revenue Growth | 4.92 | ★ 8.61 |
| 52 Week Low | $187.43 | $169.00 |
| 52 Week High | $348.90 | $228.27 |
| Indicator | WST | DRI |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 54.93 |
| Support Level | $272.53 | $184.64 |
| Resistance Level | $277.75 | $190.68 |
| Average True Range (ATR) | 5.70 | 4.40 |
| MACD | 0.42 | -0.25 |
| Stochastic Oscillator | 68.75 | 33.06 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $12.1 billion in fiscal 2025. The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales contribute modestly through the traditional grocery channel. As of the end of its fiscal 2025, the company operated 2,159 restaurants in the US.